Abstract: A process of extracting proanthocyanidins (PACs) from plant materials using an ethanol or acetone solvent is described. Plant materials from one or more plant species are mixed with ethanol or acetone at a ratio of extraction solvent to plant material between 3:1 and 8:1. The mixture is then filtered and the filtrate concentrated by evaporation. The extraction process leads to an increase in the total PAC content and in the total A-type PAC content in the degree of polymerization from dimers to pentamers. Formulations containing such PAC-enriched compositions have antioxidant, antibiotic, and antiviral properties and have a negligible allergen content.

Abstract: A low weight portable air sampling device comprising a housing at least partially enclosing an inlet for receiving an air or breath sample; a removable liner coupled to the inlet containing sorbing materials; a micro-pump for regulating air flow within the device; and an outlet for emitting the air or breath sample from the device is described. The device may be used to collect Volatile Organic Compounds (VOCs) of both biotic and abiotic origin.

Abstract: A low weight portable air sampling device comprising a housing at least partially enclosing an inlet for receiving an air or breath sample; a removable liner coupled to the inlet containing sorbing materials; a micro-pump for regulating air flow within the device; and an outlet for emitting the air or breath sample from the device is described. The device may be used to collect Volatile Organic Compounds (VOCs) of both biotic and abiotic origin.

Abstract: To improve the stability of vaccines comprising aluminum salt(s), the invention uses the amino acid histidine. This can improve pH stability and adjuvant adsorption and can reduce antigen hydrolysis. Histidine is preferably present during adsorption to the aluminum salt(s). The antigen in the vaccine may be a protein or a saccharide and is preferably from N. meningitidis.

Abstract: To improve the stability of vaccines comprising aluminum salt(s), the invention uses the amino acid histidine. This can improve pH stability and adjuvant adsorption and can reduce antigen hydrolysis. Histidine is preferably present during adsorption to the aluminum salt(s). The antigen in the vaccine may be a protein or a saccharide and is preferably from N. meningitidis.

Abstract: To improve the stability of vaccines comprising aluminum salt(s), the invention uses the amino acid histidine. This can improve pH stability and adjuvant adsorption and can be reduce antigen hydrolysis. Histidine is preferably presen during adsorption to the aluminium salt(s). The antigen in the vaccine may be a protein or a saccharide and is preferably from N. meningitidis.

Abstract: To improve the stability of vaccines comprising aluminum salt(s), the invention uses the amino acid histidine. This can improve pH stability and adjuvant adsorption and can be reduce antigen hydrolysis. Histidine is preferably presen during adsorption to the aluminium salt(s). The antigen in the vaccine may be a protein or a saccharide and is preferably from N. meningitidis.

Abstract: To improve the stability of vaccines comprising aluminum salt(s), the invention uses the amino acid histidine. This can improve pH stability and adjuvant adsorption and can reduce antigen hydrolysis. Histidine is preferably present during adsorption to the aluminum salt(s). The antigen in the vaccine may be a protein or a saccharide and is preferably from N. meningitidis.